{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T21:55:51Z","timestamp":1788904551228,"version":"build-2803163510"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>This study aims to create a model that combines ultrasonography (US), magnetic resonance imaging (MRI) examination, and clinicopathological features to predict the axillary pathological complete response (pCR) of patients with breast cancer (BC) who receive neoadjuvant therapy (NAT).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective study included 600 patients with node-positive breast cancer who were eligible for enrollment (clinical stage cT1\u20134 and cN1-3) and received neoadjuvant therapy from January 2011 to January 2024. Before biopsy and neoadjuvant therapy, these patients underwent ultrasound (US) and MRI imaging of breast lesions and axillary lymph nodes (ALNs), and clinicopathological features were recorded before and after NAT. All imaging evaluations were independently performed by two experienced breast radiologists (with &amp;gt;10 years of experience), and discrepancies were resolved by consensus. Independent risk factors for predicting ALN status after NAT were identified by univariate and multivariate analyses. These independent risk factors were used for nomogram construction.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Univariate logistic regression analysis revealed that the maximum diameter of the breast lesions on MRI after NAT (p &amp;lt; 0.001), MRI ADC-value after NAT (p &amp;lt; 0.001), maximum and minimum diameter of the ALN on US after NAT (p &amp;lt; 0.001), the Ki67 level (p &amp;lt; 0.001), tumor grade 3 (p = 0.017), primary ALN stage cN 2 (p = 0.022), efficacy evaluation of the neoadjuvant therapy, pT stage, MP classification, HR, HER2, and the presence of the Hilum of the lymph gland were significantly associated with ALN pCR after NAT (p &amp;lt; 0.05). In the multivariate logistic regression analysis, ypT2 (p &amp;lt; 0.001), ypT3 (p = 0.007), HER2 (p &amp;lt; 0.001), response PR (p = 0.007), efficacy evaluation (SD\/PD) (p = 0.010), and the presence of the Hilum of the lymph gland on US after NAT(p &amp;lt; 0.001) were considered independent predictors of ALN pCR after NAT. The area under the curve (AUC) of the nomogram was 0.934(95% CI: 0.913-0.960) in the training set and 0.908 (95% CI: 0.867-0.950) in the validation set, with a sensitivity of 82.0% and a specificity of 89.1% in the training set.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our noninvasive model based on US, MRI, and clinicopathological features can help accurately identify patients with ALN pCR after NAT and prevent unnecessary axillary lymph node dissection (ALND).<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1758310","type":"journal-article","created":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T14:24:38Z","timestamp":1775831078000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Multimodal nomogram for predicting axillary pathological complete response after neoadjuvant therapy in clinically node-positive breast cancer"],"prefix":"10.3389","volume":"16","author":[{"given":"Minyi","family":"Cheng","sequence":"first","affiliation":[{"name":"Department of Breast Cancer, Cancer Center, Guangdong Provincial People\u2019s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieqing","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Breast Cancer, Cancer Center, Guangdong Provincial People\u2019s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingyi","family":"Lin","sequence":"additional","affiliation":[{"name":"School of Medicine, South China University of Technology","place":["Guangzhou, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiachen","family":"Zou","sequence":"additional","affiliation":[{"name":"Department of Breast Cancer, Cancer Center, Guangdong Provincial People\u2019s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongqing","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Breast Cancer, Cancer Center, Guangdong Provincial People\u2019s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cangui","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Breast Cancer, Cancer Center, Guangdong Provincial People\u2019s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1093\/oxfordjournals.jncimonographs.a003469","article-title":"Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18","author":"Wolmark","year":"2001","journal-title":"J Natl Cancer Inst Monogr"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-011-2108-2","article-title":"Recommendations from an international consensus conference on the current status and future of neoadjuvant systemic therapy in primary breast cancer","volume":"19","author":"Kaufmann","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)62422-8","article-title":"Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis","volume":"384","author":"Cortazar","year":"2014","journal-title":"Lancet"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ultrasmedbio.2018.10.026","article-title":"Axillary pathologic complete response to neoadjuvant chemotherapy in clinically node-positive breast cancer patients: A predictive model integrating the imaging characteristics of ultrasound restaging with known clinicopathologic characteristics","volume":"45","author":"Kim","year":"2019","journal-title":"Ultrasound Med Biol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.ijrobp.2015.11.005","article-title":"Patterns of local-regional management following neoadjuvant chemotherapy in breast cancer: results from ACOSOG Z1071 (Alliance)","volume":"94","author":"Haffty","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(13)70166-9","article-title":"Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study","volume":"14","author":"Kuehn","year":"2013","journal-title":"Lancet Oncol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/0959-8049(92)90534-9","article-title":"Axillary dissection of level I and II lymph nodes is important in breast cancer classification. The Danish Breast Cancer Cooperative Group (DBCG)","author":"Axelsson","year":"1992","journal-title":"Eur J Cancer."},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2023.11.016","article-title":"Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"35","author":"Loibl","year":"2024","journal-title":"Ann Oncol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.07.4062","article-title":"Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011","volume":"25","author":"Lucci","year":"2007","journal-title":"J Clin Oncol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-013-3118-z","article-title":"Imaging response and residual metastatic axillary lymph node disease after neoadjuvant chemotherapy for primary breast cancer","volume":"20","author":"Hieken","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"20150143","DOI":"10.1259\/bjr.20150143","article-title":"Evaluation of lymph node status after neoadjuvant chemotherapy in breast cancer patients: comparison of diagnostic performance of ultrasound, MRI and (1)(8)F-FDG PET\/CT","volume":"88","author":"You","year":"2015","journal-title":"Br J Radiol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2014.09.020","article-title":"Noninvasive nodal restaging in clinically node positive breast cancer patients after neoadjuvant systemic therapy: a systematic review","volume":"84","author":"Schipper","year":"2015","journal-title":"Eur J Radiol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1177\/0284185117690421","article-title":"Diagnostic performance of breast ultrasonography and MRI in the prediction of lymph node status after neoadjuvant chemotherapy for breast cancer","volume":"58","author":"Ha","year":"2017","journal-title":"Acta Radiol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.57.8401","article-title":"Axillary ultrasound after neoadjuvant chemotherapy and its impact on sentinel lymph node surgery: results from the american college of surgeons oncology group Z1071 trial (Alliance)","volume":"33","author":"Boughey","year":"2015","journal-title":"J Clin Oncol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.breast.2017.05.015","article-title":"The use of ultrasound in the clinical re-staging of the axilla after neoadjuvant chemotherapy (NACT)","volume":"35","author":"Peppe","year":"2017","journal-title":"Breast."},{"key":"B16","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1634\/theoncologist.2016-0307","article-title":"Performance of mid-treatment breast ultrasound and axillary ultrasound in predicting response to neoadjuvant chemotherapy by breast cancer subtype","volume":"22","author":"Candelaria","year":"2017","journal-title":"Oncologist."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.20.5.1304","article-title":"Incidence and prognostic significance of complete axillary downstaging after primary chemotherapy in breast cancer patients with T1 to T3 tumors and cytologically proven axillary metastatic lymph nodes","volume":"20","author":"Rouzier","year":"2002","journal-title":"J Clin Oncol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.02.5023","article-title":"Outcome after pathologic complete eradication of cytologically proven breast cancer axillary node metastases following primary chemotherapy","volume":"23","author":"Hennessy","year":"2005","journal-title":"J Clin Oncol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.38.8595","article-title":"Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes","volume":"30","author":"von Minckwitz","year":"2012","journal-title":"J Clin Oncol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/s41523-025-00862-4","article-title":"Nomogram for predicting axillary pathologic complete response in cN2\u20133 breast cancer after neoadjuvant chemotherapy","volume":"11","author":"Oh","year":"2025","journal-title":"NPJ Breast Cancer."},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-016-5277-1","article-title":"Nomograms for predicting axillary response to neoadjuvant chemotherapy in clinically node-positive patients with breast cancer","volume":"23","author":"Vila","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.clbc.2013.12.015","article-title":"A model to predict pathologic complete response of axillary lymph nodes to neoadjuvant chemo(immuno)therapy in patients with clinically node-positive breast cancer","volume":"14","author":"Schipper","year":"2014","journal-title":"Clin Breast Cancer."},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.01.2898","article-title":"Nomograms to predict pathologic complete response and metastasis-free survival after preoperative chemotherapy for breast cancer","volume":"23","author":"Rouzier","year":"2005","journal-title":"J Clin Oncol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000001720","article-title":"Prognostic nomogram for prediction of axillary pathologic complete response after neoadjuvant chemotherapy in cytologically proven node-positive breast cancer","volume":"94","author":"Kim","year":"2015","journal-title":"Med (Baltimore)."},{"key":"B25","doi-asserted-by":"publisher","first-page":"5952","DOI":"10.1038\/s41598-023-29967-1","article-title":"A novel nomogram model of breast cancer-based imaging for predicting the status of axillary lymph nodes after neoadjuvant therapy","volume":"13","author":"Zhang","year":"2023","journal-title":"Sci Rep"},{"key":"B26","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1038\/srep02529","article-title":"Diagnostic and therapeutic strategy and the most efficient prognostic factors of breast Malignant fibrous histiocytoma","volume":"3","author":"Qiu","year":"2013","journal-title":"Sci Rep"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.70.5319","article-title":"Comparative analysis of human epidermal growth factor receptor 2 testing in breast cancer according to 2007 and 2013 american society of clinical oncology\/college of american pathologists guideline recommendations","volume":"35","author":"Hanna","year":"2017","journal-title":"J Clin Oncol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-9776(03)00106-1","article-title":"A new histological grading system to assess response of breast cancers to primary chemotherapy: prognostic significance and survival","volume":"12","author":"Ogston","year":"2003","journal-title":"Breast."},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.07.2460","article-title":"Cortical morphologic features of axillary lymph nodes as a predictor of metastasis in breast cancer: in vitro sonographic study","volume":"191","author":"Bedi","year":"2008","journal-title":"AJR Am J Roentgenol."},{"key":"B30","article-title":"New response evaluation criteria in solid tumours-revised RECIST guideline (version 1","volume":"36","author":"Watanabe","year":"2009","journal-title":"1)]. Gan To Kagaku Ryoho"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2019-0427","article-title":"Lymph node imaging in patients with primary breast cancer: concurrent diagnostic tools","volume":"25","author":"Marino","year":"2020","journal-title":"Oncologist."},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.35248","article-title":"An ultrasound-based nomogram for predicting axillary node pathologic complete response after neoadjuvant chemotherapy in breast cancer: Modeling and external validation","volume":"130","author":"Zheng","year":"2024","journal-title":"Cancer."},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.34540","article-title":"Deep learning radiomics of ultrasonography for comprehensively predicting tumor and axillary lymph node status after neoadjuvant chemotherapy in breast cancer patients: A multicenter study","volume":"129","author":"Gu","year":"2023","journal-title":"Cancer."},{"key":"B34","doi-asserted-by":"publisher","first-page":"21196","DOI":"10.1038\/srep21196","article-title":"A nomogram to predict the probability of axillary lymph node metastasis in early breast cancer patients with positive axillary ultrasound","volume":"6","author":"Qiu","year":"2016","journal-title":"Sci Rep"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.breast.2009.02.004","article-title":"High-resolution ultrasonographic features of axillary lymph node metastasis in patients with breast cancer","volume":"18","author":"Choi","year":"2009","journal-title":"Breast."},{"key":"B36","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1002\/1097-0142(19950101)75:1<65::aid-cncr2820750112>3.0.co;2-b","article-title":"Relationship of the size of the invasive component of the primary breast carcinoma to axillary lymph node metastasis","volume":"75","author":"Seidman","year":"1995","journal-title":"Cancer."},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/86.23.1771","article-title":"Prediction of axillary lymph node status in breast cancer patients by use of prognostic indicators","volume":"86","author":"Ravdin","year":"1994","journal-title":"J Natl Cancer Inst"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.12642","article-title":"Factors predictive of sentinel lymph node involvement in primary breast cancer","volume":"38","author":"Malter","year":"2018","journal-title":"Anticancer Res"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1758310\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T14:24:39Z","timestamp":1775831079000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1758310\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,10]]},"references-count":38,"alternative-id":["10.3389\/fonc.2026.1758310"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1758310","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,10]]},"article-number":"1758310"}}